Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-072007
Filing Date
2016-07-08
Accepted
2016-07-08 16:36:06
Documents
2
Period of Report
2016-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1773
2 poa_nolan.htm EX-24 6997
  Complete submission text file 0001140361-16-072007.txt   10194
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 36 ROCKLAND MILLS ROCKLAND DE 19732
Business Address
Nolan Lisa (Reporting) CIK: 0001661400 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 161759759